In conclusion, our study suggests that TFPI-1 is a valuable marker to predict the occurrence of DVT and tumor metastasis with a high sensitivity and specificity at the time of diagnosis of NSCLC patients. The gene discussed is TFPI; the disease is non-small cell lung carcinoma.